Dharini van der Hoeven Department of Diagnostic and Biomedical Sciences, School of Dentistry University of Texas Health Science Center Biography Publications Institution JoVE Articles Dharini van der Hoeven has not added a biography. If you are Dharini van der Hoeven and would like to personalize this page please email our Author Liaison for assistance. Publications Converting an In-person Case-based Small Group Discussion Course to a Virtual Platform Journal of Dental Education. Jun, 2020 | Pubmed ID: 32589793 Targeting Plasma Membrane Phosphatidylserine Content to Inhibit Oncogenic KRAS Function Life Science Alliance. 10, 2019 | Pubmed ID: 31451509 Discovery of High-Affinity Noncovalent Allosteric KRAS Inhibitors That Disrupt Effector Binding ACS Omega. Feb, 2019 | Pubmed ID: 30842983 HRAS-driven Cancer Cells Are Vulnerable to TRPML1 Inhibition EMBO Reports. Feb, 2019 | Pubmed ID: 30787043 Integration of Basic and Clinical Sciences: Faculty Perspectives at a U.S. Dental School Journal of Dental Education. Apr, 2018 | Pubmed ID: 29606651 Sphingomyelin Metabolism Is a Regulator of K-Ras Function Molecular and Cellular Biology. Feb, 2018 | Pubmed ID: 29158292 AMPK and Endothelial Nitric Oxide Synthase Signaling Regulates K-Ras Plasma Membrane Interactions Via Cyclic GMP-Dependent Protein Kinase 2 Molecular and Cellular Biology. 12, 2016 | Pubmed ID: 27697864 Inhibition of Acid Sphingomyelinase Depletes Cellular Phosphatidylserine and Mislocalizes K-Ras from the Plasma Membrane Molecular and Cellular Biology. 01, 2016 | Pubmed ID: 26572827 SIGNAL TRANSDUCTION. Membrane Potential Modulates Plasma Membrane Phospholipid Dynamics and K-Ras Signaling Science (New York, N.Y.). Aug, 2015 | Pubmed ID: 26293964 Another Surprise from Metformin: Novel Mechanism of Action Via K-Ras Influences Endometrial Cancer Response to Therapy Molecular Cancer Therapeutics. Dec, 2013 | Pubmed ID: 24077915 Nucleophosmin and Nucleolin Regulate K-Ras Plasma Membrane Interactions and MAPK Signal Transduction The Journal of Biological Chemistry. Oct, 2009 | Pubmed ID: 19661056 تحديد مثبطات EGFR و RAS باستخدام إليجانات Caenorhabditis Dharini van der Hoeven1,2, Thuy Nhu L. Truong1, Ali Naji1, Sabita Thapa1, John F. Hancock2, Ransome van der Hoeven1 1Department of Diagnostic and Biomedical Sciences, School of Dentistry, University of Texas Health Science Center, 2Department of Integrative Biology and Pharmacology, McGovern Medical School, University of Texas Health Science Center JoVE 61788 Cancer Research
تحديد مثبطات EGFR و RAS باستخدام إليجانات Caenorhabditis Dharini van der Hoeven1,2, Thuy Nhu L. Truong1, Ali Naji1, Sabita Thapa1, John F. Hancock2, Ransome van der Hoeven1 1Department of Diagnostic and Biomedical Sciences, School of Dentistry, University of Texas Health Science Center, 2Department of Integrative Biology and Pharmacology, McGovern Medical School, University of Texas Health Science Center JoVE 61788 Cancer Research
